- Exclusive: Restaurant chain Chuck E. Cheese prepares IPO - sources
- U.S. jeweler Claire's abandons plan to go public
- Exclusive: Morgan Stanley cuts bankers, bonuses as deals, IPOs stall - sources
- Keane Group Launches IPO; Plan to Offer 15.3M Shares at $17-$19, List Under Ticker 'FRAC'
- Jounce Therapeutics Files $75M IPO, Plans to List on NASDAQ Under the Symbol 'JNCE'
- See More
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
|12/16/2016||trivago||TRVG||26.1 Bil||$11.00||$11.75||6.82%||.P. Morgan Securities LLC, Goldman, Sachs & Co. and Morgan Stanley & Co. LLC|
|12/14/2016||WildHorse Resource Development||WRD||27.5 Mil||$15.00||$14.60||-2.67%||Barclays, BofA Merrill Lynch, BMO Capital Markets, Citigroup and Wells Fargo|
|12/8/2016||SenesTech||SNES||1.875 Mil||$8.00||$8.15||1.88%||Roth Capital Partners|
|12/7/2016||Polar Power||POLA||2.4 Mil||$7.00||$8.95||27.86%||Roth Capital Partners and Joseph Gunnar & Co|
|11/18/2016||Motif Bio plc||MTFB||2.44 Mil||$6.98||$6.19||-11.32%||H.C. Wainwright|
|11/4/2016||Smart Sand||SND||11.7 Mil||$11.00||$16.55||50.45%|
|11/2/2016||GDS Holdings||GDS||19.25 Mil||$10.00||$8.60||-14.00%||Credit Suisse, JPMorgan, Citigroup, RBC, China Renaissance|
|10/28/2016||Acushnet Holdings||GOLF||19.333 Mil||$17.00||$19.71||15.94%||J.P. Morgan, Morgan Stanley|
|10/28/2016||BlackLine||BL||8.6 Mil||$17.00||$27.63||62.53%||Goldman, Sachs & Co. and J.P. Morgan|
|10/28/2016||Quantenna Communications||QNTA||6.7 Mil||$16.00||$2.80||-82.50%||Morgan Stanley, Barclays, Deutsche Bank|
|N/A||Clipper Realty Inc.||CLPR||N/A||N/A||FBR|
|N/A||Viamet Pharmaceuticals Corp.||VMET||N/A||N/A||Morgan Stanley, Goldman, Sachs & Co., Guggenheim Securities, Needham & Company|
|N/A||MassRoots, Inc.||MSRT||N/A||N/A||Chardan Capital Markets|
|N/A||Ardagh Finance Holdings S.A.||ARD||N/A||N/A||Citigroup|
|N/A||Gemphire Therapeutics||GEMP||N/A||N/A||Jefferies and Cowen|
|N/A||Myovant Sciences Ltd.||MYOV||N/A||N/A||Citigroup, Cowen and Company, Evercore ISI, Barclays|
|N/A||OrthoPediatrics Corp.||KIDS||N/A||N/A||Piper Jaffray & Co., Stifel, Nicolaus & Company, William Blair & Company, BTIG|
|N/A||BeyondSpring||BYSI||N/A||N/A||Citigroup, Guggenheim Securities, FBR, China Renaissance, Trout Capital|
|N/A||YETI Holdings, Inc.||YETI||N/A||N/A||BofA Merrill Lynch, Morgan Stanley, Baird, Piper Jaffray, Jefferies, William Blair, KeyBanc Capital Markets, SunTrust Robinson Humphrey, Wells Fargo Securities, Raymond James, Stifel, Academy Securities|
|N/A||JBS Foods International B.V.||JBS||N/A||N/A|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.